Research & development

Award for Australian seismologist

30 January, 2008

A seismologist from The Australian National University (ANU), whose work could help forecast the damage path of future earthquakes, has been honoured by one of the world’s top scientific organisations.


Protein discovery offers hope for prostate cancer

21 January, 2008

Australian scientists are researching a possible way of making aggressive prostate cancer cells less invasive after their discovery of a protein essential for the normal functioning of cells.


Scientists solve hot reptile sex question

21 January, 2008

University of Sydney researchers have finally solved a conundrum scientists have been puzzling over for 30 years: why nest temperature can affect the likelihood of certain reptiles being born male or female.


Researchers create metal memory foam

27 December, 2007

In the world of commercial materials, lighter and cheaper is usually better — especially when those attributes are coupled with superior strength and special properties, such as a recently developed material's ability to remember its original shape after it has been deformed by a physical or magnetic force.


Developing therapy-resistant cancers for research

17 December, 2007

A cancer cell line that is resistant to one of the newest classes of cancer treatments has been developed by researchers who already are using it to determine treatment alternatives for when it starts appearing in patients.


Violent sex acts boost insect's immune system

10 December, 2007

Scientists have discovered that many insects have a form of immune memory similar to the vertebrate system, which protects them against reinvasion by previously encountered pathogens.


Could lithium medicine prolong your life?

06 December, 2007 by Keiran Jones, Journalist

The common mood-affecting drug, lithium, could double as an anti-ageing medication, according to a recent study in the online version of the Journal of Biological Chemistry


Growing human embryonic stem cells

06 December, 2007 | Supplied by: Life Technologies

Human embryonic stem cells (hESCs), the building blocks for all cell types in the human body, may be harnessed for potential applications in cell therapy and regenerative medicine. Currently, hESC culture and expansion methods require the use of serum, mouse or human fibroblast feeder layers, or feeder-conditioned medium. These culture methods are labour intensive and hard to scale, and it is difficult to maintain hESCs in an undifferentiated state because of significant sources of variability such as growth factor fluctuations during culture.


Research links stress to ADHD

05 December, 2007

Researchers from the University of Melbourne and the Howard Florey Institute have discovered a biological cause for why children with ADHD are not able to handle stressful environments.


Research collaboration for green manufacturing systems

04 December, 2007

A research alliance has recently been announced between the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) and The Dow Chemical Company.


A fresh FACE for climate research

03 December, 2007

Scientists will have access to the latest in climate change technology to investigate future atmospheric conditions and their impact on plant crops, after the official opening in November of a $3.7 million climate change research facility in Horsham, Victoria.


Advances in early stage ovarian cancer diagnosis

30 November, 2007

HealthLinx has reached an agreement with The University of Liverpool (UK) to in-license patented biomarkers and antibodies that show efficacy in detecting grade one and two ovarian cancer.


Alzheimer's vaccine gets European patent

29 November, 2007

The Vienna-based company, Affiris, announced that it has been granted a Europe-wide patent for a pool of peptide sequences that are key elements of its Alzheimer’s vaccine. The company will be able to use these newly patented components to manufacture an optimised vaccine against beta-amyloid, the peptide responsible for the onset of Alzheimer’s disease.


A guide to inhibit measles infection

26 November, 2007

Infecting almost 20 million people worldwide each year, the measles virus remains a dangerous, highly contagious disease despite extensive vaccination efforts. However, recent advancements in understanding the pathogen’s binding mechanism could provide a new strategy to fight infection.


EMBO elects three top Australian scientists

26 November, 2007

Three Australian scientists have been elected as members of the European Molecular Biology Organization (EMBO), one of the world’s most respected scientific organisations.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd